Inter Pharma PCL (BKK:IP) FCF Margin % : -7.81% (As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Inter Pharma PCL FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Inter Pharma PCL's Free Cash Flow for the three months ended in Dec. 2024 was ฿-42 Mil. Inter Pharma PCL's Revenue for the three months ended in Dec. 2024 was ฿532 Mil. Therefore, Inter Pharma PCL's FCF Margin % for the quarter that ended in Dec. 2024 was -7.81%.

As of today, Inter Pharma PCL's current FCF Yield % is -3.81%.

The historical rank and industry rank for Inter Pharma PCL's FCF Margin % or its related term are showing as below:

BKK:IP' s FCF Margin % Range Over the Past 10 Years
Min: -30.75 Med: -2.84 Max: 6.11
Current: -4.41

During the past 8 years, the highest FCF Margin % of Inter Pharma PCL was 6.11%. The lowest was -30.75%. And the median was -2.84%.

BKK:IP's FCF Margin % is ranked better than
74.28% of 1011 companies
in the Biotechnology industry
Industry Median: -137.96 vs BKK:IP: -4.41

Inter Pharma PCL FCF Margin % Historical Data

The historical data trend for Inter Pharma PCL's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inter Pharma PCL FCF Margin % Chart

Inter Pharma PCL Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

FCF Margin %

Get a 7-Day Free Trial

-5.27

-30.75

6.11

-1.27

-4.41

Inter Pharma PCL Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
FCF Margin %	Get a 7-Day Free Trial															-1.61	2.30	-2.94	-9.20	-7.81

Competitive Comparison of Inter Pharma PCL's FCF Margin %

For the Biotechnology subindustry, Inter Pharma PCL's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Inter Pharma PCL's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Inter Pharma PCL's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Inter Pharma PCL's FCF Margin % falls into.

Save Embed

;

Save Embed

;

Inter Pharma PCL FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Inter Pharma PCL's FCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2024 )	/	Revenue (A: Dec. 2024 )
	=	-83.621	/	1897.33
	=	-4.41 %

Inter Pharma PCL's FCF Margin for the quarter that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	-41.551	/	531.951
	=	-7.81 %

Inter Pharma PCL FCF Margin % Related Terms

Thank you for viewing the detailed overview of Inter Pharma PCL's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Inter Pharma PCL Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Inter Pharma PCL (BKK:IP) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Silom Road, 140/9 ITF Tower 9th Floor, Suriyawongse, Bangrak, Bangkok, THA, 10500

Website

https://www.interpharma.co.th

Inter Pharma PCL is a biopharmaceutical company. It is engaged in the import, manufacture and distribution of drug, and dietary supplement products for humans and animals. It offers products related to Wellness and Anti-aging, Aesthetics, Diagnostics, Vitamins, and other products. The company operates in three reportable segments Human healthcare, Animal Healthcare, and Hospital and clinics in Thailand. Key revenue is derived from the Human healthcare segment.